Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1991 Apr;63(4):550–552. doi: 10.1038/bjc.1991.129

Raynaud's phenomenon after combination chemotherapy of testicular cancer, measured by laser Doppler flowmetry. A pilot study.

M S Heier 1, T Nilsen 1, V Graver 1, N Aass 1, S D Fosså 1
PMCID: PMC1972340  PMID: 1850610

Abstract

The pathophysiology of Raynaud's phenomenon after Cisplatin-Bleomycin-Vinblastine combination chemotherapy, its relationship to polyneuropathy, and response to transcutaneous nerve stimulation (TNS), was studied in eight patients previously treated for testicular cancer. Peripheral circulation in the index finger was measured by laser Doppler flowmetry before and after cold provocation. In all patients there was an exaggerated and prolonged vasoconstrictor response to cold, with a mean flux reduction of 61%, and a mean restitution time of greater than 7 min, characteristic of Raynaud's phenomenon of the vasospastic type. The normal controls had a mean flux reduction of 24% and a restitution time of 1.5 min. Clinical examination and nerve conduction measurements revealed a mild polyneuropathy in five of the eight patients, but an etiological relationship with Raynaud's phenomenon could not be ascertained. There was no measurable effect of TNS.

Full text

PDF
551

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aass N., Kaasa S., Lund E., Kaalhus O., Heier M. S., Fosså S. D. Long-term somatic side-effects and morbidity in testicular cancer patients. Br J Cancer. 1990 Jan;61(1):151–155. doi: 10.1038/bjc.1990.31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Casey E. B., Jellife A. M., Le Quesne P. M., Millett Y. L. Vincristine neuropathy. Clinical and electrophysiological observations. Brain. 1973;96(1):69–86. doi: 10.1093/brain/96.1.69. [DOI] [PubMed] [Google Scholar]
  3. Hansen S. W., Helweg-Larsen S., Trojaborg W. Long-term neurotoxicity in patients treated with cisplatin, vinblastine, and bleomycin for metastatic germ cell cancer. J Clin Oncol. 1989 Oct;7(10):1457–1461. doi: 10.1200/JCO.1989.7.10.1457. [DOI] [PubMed] [Google Scholar]
  4. Hansen S. W., Olsen N. Raynaud's phenomenon in patients treated with cisplatin, vinblastine, and bleomycin for germ cell cancer: measurement of vasoconstrictor response to cold. J Clin Oncol. 1989 Jul;7(7):940–942. doi: 10.1200/JCO.1989.7.7.940. [DOI] [PubMed] [Google Scholar]
  5. Horrobin D. F., Jenkins K., Manku M. S. Raynaud's phenomenon, histamine, and prostaglandins. Lancet. 1983 Sep 24;2(8352):747–748. doi: 10.1016/s0140-6736(83)92289-4. [DOI] [PubMed] [Google Scholar]
  6. Kaada B., Olsen E., Eielsen O. In search of mediators of skin vasodilation induced by transcutaneous nerve stimulation: III. Increase in plasma VIP in normal subjects and in Raynaud's disease. Gen Pharmacol. 1984;15(2):107–113. doi: 10.1016/0306-3623(84)90091-0. [DOI] [PubMed] [Google Scholar]
  7. Kaada B. Vasodilation induced by transcutaneous nerve stimulation in peripheral ischemia (Raynaud's phenomenon and diabetic polyneuropathy). Eur Heart J. 1982 Aug;3(4):303–314. doi: 10.1093/oxfordjournals.eurheartj.a061312. [DOI] [PubMed] [Google Scholar]
  8. Kaplan R. S., Wiernik P. H. Neurotoxicity of antineoplastic drugs. Semin Oncol. 1982 Mar;9(1):103–130. [PubMed] [Google Scholar]
  9. Keenan E. J., Porter J. M. Alpha-adrenergic receptors in platelets from patients with Raynaud's syndrome. Surgery. 1983 Aug;94(2):204–209. [PubMed] [Google Scholar]
  10. Lafferty K., De Trafford J. C., Roberts V. C., Cotton L. T. On the nature of Raynaud's phenomenon: the role of histamine. Lancet. 1983 Aug 6;2(8345):313–315. doi: 10.1016/s0140-6736(83)90292-1. [DOI] [PubMed] [Google Scholar]
  11. Low P. A., Neumann C., Dyck P. J., Fealey R. D., Tuck R. R. Evaluation of skin vasomotor reflexes by using laser Doppler velocimetry. Mayo Clin Proc. 1983 Sep;58(9):583–592. [PubMed] [Google Scholar]
  12. Nilsson G. E., Tenland T., Oberg P. A. Evaluation of a laser Doppler flowmeter for measurement of tissue blood flow. IEEE Trans Biomed Eng. 1980 Oct;27(10):597–604. doi: 10.1109/TBME.1980.326582. [DOI] [PubMed] [Google Scholar]
  13. Roelofs R. I., Hrushesky W., Rogin J., Rosenberg L. Peripheral sensory neuropathy and cisplatin chemotherapy. Neurology. 1984 Jul;34(7):934–938. doi: 10.1212/wnl.34.7.934. [DOI] [PubMed] [Google Scholar]
  14. Salerud E. G., Tenland T., Nilsson G. E., Oberg P. A. Rhythmical variations in human skin blood flow. Int J Microcirc Clin Exp. 1983;2(2):91–102. [PubMed] [Google Scholar]
  15. Thompson S. W., Davis L. E., Kornfeld M., Hilgers R. D., Standefer J. C. Cisplatin neuropathy. Clinical, electrophysiologic, morphologic, and toxicologic studies. Cancer. 1984 Oct 1;54(7):1269–1275. doi: 10.1002/1097-0142(19841001)54:7<1269::aid-cncr2820540707>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  16. Vogelzang N. J., Bosl G. J., Johnson K., Kennedy B. J. Raynaud's phenomenon: a common toxicity after combination chemotherapy for testicular cancer. Ann Intern Med. 1981 Sep;95(3):288–292. doi: 10.7326/0003-4819-95-3-288. [DOI] [PubMed] [Google Scholar]
  17. Vogelzang N. J., Torkelson J. L., Kennedy B. J. Hypomagnesemia, renal dysfunction, and Raynaud's phenomenon in patients treated with cisplatin, vinblastine, and bleomycin. Cancer. 1985 Dec 15;56(12):2765–2770. doi: 10.1002/1097-0142(19851215)56:12<2765::aid-cncr2820561208>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES